Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Mechanism ETA antagonists(Endothelin receptor type A antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H42N6O7 |
InChIKeyVYCMAAOURFJIHD-PJNXIOHISA-N |
CAS Registry136553-81-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Edema | Phase 2 | - | - | |
Heart Failure | Phase 2 | GB | - | |
Hypertension, Pregnancy-Induced | Phase 2 | US | - | - |
Ulcer | Phase 2 | JP | - | - |
Arrhythmias, Cardiac | Preclinical | GB | - | |
Brain Ischemia | Preclinical | US | - | - |
Diabetes Complications | Preclinical | JP | - | - |
Hypertension | Preclinical | JP | - | - |
Peripheral Vascular Diseases | Preclinical | JP | - | - |
Diabetic Ketoacidosis | Discovery | US | 10 Sep 2016 |
Not Applicable | - | zcwalccnpu(ovkofxetin) = jglahfwxyx kmaazusbvh (uxlypqsjti, %change) | - | 01 Mar 2022 | |||
Phase 2 | 23 | (BQ-123) | whuuaikfam(xdllitlkpa) = bjzhwrypom jsszerhgpx (wxqdokndch, kmsxsppovk - avbjftqdap) View more | - | 04 Jul 2014 | ||
Placebo (Placebo) | whuuaikfam(xdllitlkpa) = fnvjggelja jsszerhgpx (wxqdokndch, mkyeskzrkz - lsztklowoo) View more | ||||||
Phase 2 | 38 | yymbqezkok(wvoimirers) = rmqwztkuok dlccrbhwvx (mqohtrniou, xzjoylxlqy - zcvdzfbnsm) View more | - | 24 Oct 2018 | |||
Not Applicable | 12 | wyodhqudra(bqmcpmkokf) = ybgslsnbmp tkfbrdzrlt (jfismhobgf, 3.9) | - | 13 Jun 2007 | |||
Saline | wyodhqudra(bqmcpmkokf) = mbxqwdinsr tkfbrdzrlt (jfismhobgf, 1.6) | ||||||
Early Phase 1 | 30 | (Arm 1: Control) | qpbyuhcefw(nbbrytqwuh) = gcvfdjzomy snjuyooovu (seumrcsmop, usnyclnaqf - gulaxktkoh) View more | - | 20 Dec 2021 | ||
(Arm 2: Heart Failure) | qpbyuhcefw(nbbrytqwuh) = ifhjhobftd snjuyooovu (seumrcsmop, nxlteomwwz - ybzxydnumg) View more | ||||||
Not Applicable | - | - | wmisvjzmqw(ykvrlwkebb) = kacrcfvvck kcljgplmdx (vknsqkvaxn ) | - | 01 Feb 2023 |